US2022195409A1PendingUtilityA1
Simultaneous multiplex genome editing in yeast
Est. expiryMar 25, 2039(~12.7 yrs left)· nominal 20-yr term from priority
C12N 15/102C12N 2800/80C12N 2310/20C12N 9/22C12Q 1/44C12N 15/85C12N 15/113C12N 15/90C12N 2310/128C12N 15/81C12N 15/63
79
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides compositions of matter, methods and instruments for editing nucleic acids in live yeast cells.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for performing simultaneous multiplex RNA-directed nuclease editing in yeast cells using libraries of linear vector backbones and a library of editing cassettes constructs comprising:
providing:
a first linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a first antibiotic resistance gene, and a yeast origin of replication;
a second linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a second antibiotic resistance gene, and a yeast origin of replication; and
a library of editing cassette constructs, wherein each editing cassette construct comprises from 5′ to 3′: a pol II promoter; a transcription start site; a first editing cassette wherein the first editing cassette comprises a coding sequence for a first gRNA and a coding sequence for a first donor DNA, wherein the first donor DNA comprises a rational, desired edit to a first target sequence and an edit configured to render inactive a first proto-spacer motif (PAM) in the first target sequence; a tRNA linker; a second editing cassette wherein the second editing cassette comprises a coding sequence for a second gRNA and a coding sequence for a second donor DNA, wherein the second donor DNA comprises a rational, desired edit to a second target sequence and an edit configured to render inactive a second proto-spacer motif (PAM) in the second target sequence; a coding sequence for a self-cleaving ribozyme; and a pol II terminator; wherein the first and second editing cassettes in the library of editing cassette constructs are different among editing cassettes constructs, and wherein homology exists between the library of editing cassette constructs and the first and second linear vector backbones;
amplifying the library of editing cassette constructs to create an amplified library of editing cassette constructs; transforming the yeast cells with the amplified library of editing cassettes constructs and the first and second linear vector backbones, wherein gap repair combines the amplified library of editing cassettes and first and second linear vector backbones to form editing vectors; and providing conditions for RNA-directed nuclease editing of the yeast cells by the editing vectors.
2 . The method of claim 1 , further comprising a step of providing a third linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a third antibiotic resistance gene, and a yeast origin of replication, and wherein homology exists between the library of editing cassettes and the third linear vector backbone.
3 . The method of claim 2 , further comprising a step of providing a fourth linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a fourth antibiotic resistance gene, and a yeast origin of replication, and wherein homology exists between the library of editing cassettes and the fourth linear vector backbones.
4 . The method of claim 1 , wherein the coding sequence for the nuclease in the first and second linear vector backbones is the coding sequence for the same nuclease.
5 . The method of claim 1 , wherein the first antibiotic resistance gene confers resistance to hygromycin and the second antibiotic resistance gene confers resistance to G418.
6 . The method of claim 1 , wherein the first and second linear vector backbones comprise the pol II promoter to drive expression of the editing cassette construct.
7 . The method of claim 1 , wherein each linear vector backbone further comprises an origin of replication functional in bacteria.
8 . The method of claim 1 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in a hepatitis delta virus (HDV)-like ribozyme family, a self-cleaving ribozyme in a glucosamine-6-phosphate synthase ribozyme family, a self-cleaving ribozyme in a hammerhead ribozyme family, a self-cleaving ribozyme in a hairpin ribozyme family, a self-cleaving ribozyme in a Neurospora Varkud satellite ribozyme family, a self-cleaving ribozyme in a twister ribozyme family, a self-cleaving ribozyme in a twister sister ribozyme family, a self-cleaving ribozyme in a hatchet ribozyme family, or a self-cleaving ribozyme in a pistol ribozyme family.
9 . The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the hepatitis delta virus (HDV)-like ribozyme family.
10 . The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the glucosamine-6-phosphate synthase ribozyme family.
11 . The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the Neurospora Varkud satellite ribozyme family.
12 . The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the twister ribozyme family.
13 . The method of claim 8 , wherein the self-cleaving ribozyme is a self-cleaving ribozyme in the twister sister ribozyme family.
14 . The method of claim 1 , comprising a second self-cleaving ribozyme 3′ of the transcription start site and 5′ of the first editing cassette.
15 . The method of claim 1 , wherein the pol II promoter is a cell-type specific promoter, a tissue-specific promoter, or a synthetic promoter.
16 . The method of claim 1 , wherein the pol II promoter is a constitutive fungal promoter.
17 . The method of claim 16 , wherein the constitutive fungal pol II promoter is a pPGK1, pTDH3, pENO2, pADH1, pTPI1, pTEF1, pTEF2, pYEF3, pRPL3, pRPL15A, pRPL4, pRPL8B, pSSA1, pSSB1, pCYC1, or pPDA1 promoter.
18 . The method of claim 1 , wherein the tRNA linker is an alanine tRNA.
19 . The method of claim 1 , wherein the tRNA linker is a glycine tRNA.
20 . The method of claim 1 , wherein the tRNA linker is a threonine tRNA.
21 . The method of claim 1 , wherein the pol II promoter is a constitutive mammalian promoter.
22 . The method of claim 21 , wherein the pol II promoter is a pCMV, pEF1a, pSV40, pPGK1, pUbc, human beta actin promoter, or pCAG promoter.
23 . The method of claim 1 , wherein the pol II promoter is an inducible promoter.
24 . The method of claim 23 , wherein an inducible promoter is a PHOS promoter, a METS promoter, a CUP1 promoter, a GAL1 promoter, or a GEV or LEV promoter system.
25 . The method of claim 1 , wherein the first gRNA in the first editing cassette is 5′ of the first donor DNA and wherein the second gRNA in the second editing cassette is 5′ of the second donor DNA.
26 . The method of claim 1 , wherein the first gRNA in the first editing cassette is 3′ of the first donor DNA and wherein the second gRNA in the second editing cassette is 3′ of the second donor DNA.
27 . A method for performing simultaneous multiplex RNA-direct nuclease editing in yeast cells using a library of linear vector backbones and a library of editing cassettes constructs comprising:
providing:
a first linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a first antibiotic resistance gene, and a yeast origin of replication;
a second linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a second antibiotic resistance gene, and a yeast origin of replication;
a third linear vector backbone comprising a coding sequence for a nuclease, a coding sequence for a third antibiotic resistance gene, and a yeast origin of replication;
a library of editing cassette constructs, wherein each editing cassette construct comprises from 5′ to 3′: a pol II promoter; a transcription start site; a first editing cassette wherein the first editing cassette comprises a coding sequence for a first gRNA and a coding sequence for a first donor DNA, wherein the first donor DNA comprises a rational, desired edit to a first target sequence and an edit configured to render inactive a first proto-spacer motif (PAM) in the first target sequence; a tRNA linker; a second editing cassette wherein the second editing cassette comprises a coding sequence for a second gRNA and a coding sequence for a second donor DNA, wherein the second donor DNA comprises a rational, desired edit to a second target sequence and an edit configured to render inactive a second proto-spacer motif (PAM) in the second target sequence; a coding sequence for a self-cleaving ribozyme; and a pol II terminator; wherein the first and second editing cassettes in the library of editing cassette constructs are different among editing cassettes constructs, and wherein homology exists between the library of editing cassette constructs and the first, second and third linear vector backbones;
amplifying the library of editing cassette constructs to create an amplified library of editing cassette constructs; transforming the yeast cells with the amplified library of editing cassettes constructs and the first, second and third linear vector backbones, wherein gap repair combines the amplified library of editing cassettes and first, second and third linear vector backbones to form editing vectors; and providing conditions for RNA-directed nuclease editing of the yeast cells by the editing vectors.
28 . The method of claim 27 , wherein the tRNA linker is an alanine tRNA.
29 . The method of claim 27 , wherein the tRNA linker is a glycine tRNA.
30 . The method of claim 27 , wherein the tRNA linker is a threonine tRNA.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.